Precision health is emerging as a major investment opportunity, with technologies ranging from GLP-1 care and biosensors to personalized nutrition and AI-driven preventive medicine. According to AgFunderNews, Cornucopian Capital, led by founder and managing partner Aryeh Ganz, is building an investment strategy focused on commercializing university research and scaling technologies that could make personalized healthcare more accessible.
Joe Wang
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Joe
Contact Joe, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack